(Q43580879)

24 November 2017

Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-gamma (English)

1 reference

experimental autoimmune encephalomyelitis

24 November 2017

0 references

author name string

Niino M

1

1 reference

24 November 2017

Iwabuchi K

2

1 reference

24 November 2017

Kikuchi S

3

1 reference

24 November 2017

Ato M

4

1 reference

24 November 2017

Morohashi T

5

1 reference

24 November 2017

Ogata A

6

1 reference

24 November 2017

Tashiro K

7

1 reference

24 November 2017

Onoé K

8

1 reference

24 November 2017

1 May 2001

1 reference

Journal of Neuroimmunology

24 November 2017

1 reference

24 November 2017

116

1 reference

24 November 2017

1

1 reference

24 November 2017

40-48

1 reference

Differential cytokine expression in acute and chronic murine graft-versus-host-disease

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

A novel antidiabetic drug, troglitazone--reason for hope and concern

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

Induction of CTL responses by simultaneous administration of liposomal peptide vaccine with anti-CD40 and anti-CTLA-4 mAb

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

Csk overexpression reduces several monokines and nitric oxide productions but enhances prostaglandin E2 production in response to lipopolysaccharide in the macrophage cell line J774A.1.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

Differential expression and activation of a family of murine peroxisome proliferator-activated receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

Unimpaired autoreactive T-cell traffic within the central nervous system during tumor necrosis factor receptor-mediated inhibition of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

The nuclear receptor superfamily: the second decade

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

Protective effect of the interleukin-1 receptor antagonist (IL-1ra) on experimental allergic encephalomyelitis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp-lpr/lpr mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

Amelioration of experimental autoimmune uveoretinitis by pretreatment with a pathogenic peptide in liposome and anti-CD40 ligand monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

Anti?tumor necrosis factor therapy abrogates autoimmune demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2801%2900285-5

7 January 2021

10.1016/S0165-5728(01)00285-5

Identifiers

DOI

1 reference

24 November 2017

1 reference